#BIOASIA18: Become Trend on twitter at (2018-03-12 12:04)


People talking about #BIOASIA18: - KellyFegrate - LaurusT001 - peterkcrane - Idreamforward - annualtrig - LaurusT001 - freddynietzschy - BioWorld - portefeuillefun - BioWorld[...]
- EMcCallister01 - BioPharmaJosh - EMcCallister01 - BioPharmaJosh - LaurusT001 - BioWorld - BioWorld - SclerodermaRF - mfitz - LaurusT001 - BioWorld - BioWorld - mfitz - MyleaCharvat - archilys_1st - BioWorld - BioWorld - WGan915 - BioWorld - grumpeoldman - BioWorld - BioWorld - EMcCallister01 - VikasReports - AHimar33 - CEOCorbus - BioWorld - BioWorld - BioPharmaJosh - mfitz - BioWorld - BioWorld - BioWorld - BioPharmaJosh - BrainstormCell - mariempowers - BioWorld - AlmacGroup - BioWorld - mariempowers - BioWorld - JohnstonDon - mariempowers - BioWorld - mfitz - EmoryOTT - bio1x1 - Inova_Software - BioPartner - AlmacGroup

This Tag appearing in: United States: ( Albuquerque - Atlanta - Austin - Baltimore - Baton Rouge - Birmingham - Boston - Charlotte - Chicago - Cincinnati - Cleveland - Colorado Springs - Columbus - Dallas-Ft. Worth - Denver - Detroit - El Paso - Fresno - Greensboro - Harrisburg - Honolulu - Houston - Indianapolis - Jackson - Jacksonville - Kansas City - Las Vegas - Long Beach - Los Angeles - Louisville - Memphis - Mesa - Miami - Milwaukee - Minneapolis - Nashville - New Haven - New Orleans - New York - Norfolk - Oklahoma City - Omaha - Orlando - Philadelphia - Phoenix - Pittsburgh - Portland - Providence - Raleigh - Richmond - Sacramento - St. Louis - Salt Lake City - San Antonio - San Diego - San Francisco - San Jose - Seattle - Tallahassee - Tampa - Tucson - Virginia Beach - Washington - United States - ).
Popular tweets tagged with #BIOASIA18:
#BIOASIA18 Josh Berlin @BioPharmaJoshπŸ”We're at #BIOASIA18 today in Tokyo - great turnout and a lot of energy.
loading...
#BIOASIA18 Murali Neelakantan @grumpeoldmanπŸ” Licensing deals on the rise for Japanese biopharma companies (data from JBA) #BIOASIA18
#BIOASIA18 Yuval Cohen @CEOCorbusπŸ”Konichiwa #BIOASIA18 ! It's @CorbusPharma first time here and we're thrilled!
#BIOASIA18 Josh Berlin @BioPharmaJoshπŸ”Licensing deals on the rise for Japanese biopharma companies (data from JBA) #BIOASIA18
#BIOASIA18 bemybaby @archilys_1stπŸ” We're at #BIOASIA18 today in Tokyo - great turnout and a lot of energy.
#BIOASIA18 SclerodermaRF @SclerodermaRFπŸ” Konichiwa #BIOASIA18 ! It's @CorbusPharma first time here and we're thrilled!
Laurus @LaurusT001πŸ”The stars have aligned in the Hong Kong market, says Michael Chan, SVP of HKEX, with 3 pools of investors fueling liquidity: Western institutional investors, Asian investors inc. sovereign wealth, and mainland Chinese investors, unable to invest abroad, coming to HK
Dr. Regina D. Ponder @IdreamforwardπŸ”Hong Kong Exchange poised to start accepting applications for listing from pre-revenue companies by May as it embraces ever-earlier entrepreneurs. One investment manager tells us pre-IPO road shows have already begun as i-bankers try to nail pricing.
annualtrig @annualtrigπŸ”In other words it is necessary that he should have the mentality appropriate to a state of war. #BIOASIA18
Laurus @LaurusT001πŸ” For example, truth should keep away from one can be! #BIOASIA18
Friedrich Nietzsche @freddynietzschyπŸ”For example, truth should keep away from one can be! #BIOASIA18
BioWorld @BioWorldπŸ”The stars have aligned in the Hong Kong market, says Michael Chan, SVP of HKEX, with 3 pools of investors fueling liq twitter.com uidity: Western institutional investors, Asian investors inc. sovereign wealth, and mainland Chinese investors, unable to invest abroad, coming to HK
Volker Schulz @portefeuillefunπŸ”Hong Kong is accelerating its plans, biotech listing rules will be finalized in April, 1st IPO applications in May - Michael Chan, HKEX
BioWorld @BioWorldπŸ”VelocityHealth Securities director Dale Yakin says returnees to Asian markets from the west have raised the level of twitter.com sophistication in licensing talks. Single question talks ("How much do you want?") have given way to nuanced deal discussions.
Erin McCallister @EMcCallister01πŸ”Great panel on Asia platform plays moderated by my colleague -> diverse group but all agreed on 1 point: the most important differentiator is talent, talent, talent
Josh Berlin @BioPharmaJoshπŸ”Great panel on Asia platform plays moderated by my colleague -> diverse group but all agreed on 1 point: the most im twitter.com portant differentiator is talent, talent, talent
Erin McCallister @EMcCallister01πŸ”Note to small companies, from Takeda strategy & portfolio expert Neil Lineberry: Emphasize portfolio quality over quantity. Don't try to create value just by covering the waterfront.
Josh Berlin @BioPharmaJoshπŸ”Hong Kong is accelerating its plans, biotech listing rules will be finalized in April, 1st IPO applications in May - twitter.com Michael Chan, HKEX
BioWorld @BioWorldπŸ”Hong Kong Exchange poised to start accepting applications for listing from pre-revenue companies by May as it embrace twitter.com s ever-earlier entrepreneurs. One investment manager tells us pre-IPO road shows have already begun as i-bankers try to nail pricing.
BioWorld @BioWorldπŸ”Mabspace Biosciences CEO Xueming Qian says its PD-L1 antibody, MBS-2311, is poised to enter the clinic next week. #BIOASIA18
Laurus @LaurusT001πŸ”Takeda strategy & portfolio expert Neil Lineberry: The bar for getting noticed (by big pharma) keeps moving. Aspirants need to ask not what difference their drug will have now, but tomorrow. Said he's always looking 5 to 10 years ahead.
BioWorld @BioWorldπŸ”Takeda strategy & portfolio expert Neil Lineberry: The bar for getting noticed (by big pharma) keeps moving. Aspirant twitter.com s need to ask not what difference their drug will have now, but tomorrow. Said he's always looking 5 to 10 years ahead.
BioWorld @BioWorldπŸ”Note to small companies, from Takeda strategy & portfolio expert Neil Lineberry: Emphasize portfolio quality over qua twitter.com ntity. Don't try to create value just by covering the waterfront.
Michael Fitzhugh @mfitzπŸ”Note to small companies, from Takeda strategy & portfolio expert Neil Lineberry: Emphasize portfolio quality over qua twitter.com ntity. Don't try to create value just by covering the waterfront.
Mylea Charvat, PhD @MyleaCharvatπŸ”I’ll be at #bioasia18 giving a talk at 11:15am local time. Look forward to seeing you there!
BioWorld @BioWorldπŸ”Stacey said his team is looking to learn about how to position the product (for managing the metabolic processes asso twitter.com ciated with Alzheimer's disease), differently and to take those learnings back to the west.
BioWorld @BioWorldπŸ”Moving on after misfortune in NOURISH AD trial, medical food specialist Accera is building a team in Singapore to hel twitter.com p manage its entry to China. Has 30-40 Chinese cos. interested in partnership, CEO Charles Stacey said at
WGI @WGan915πŸ”Think your company is lean? MediciNova, a company with dual public listings on Nasdaq and Jasdaq has SEVEN employees, CEO and president Yuichi Iwaki said at today.
BioWorld @BioWorldπŸ”Think your company is lean? MediciNova, a company with dual public listings on Nasdaq and Jasdaq has SEVEN employees, twitter.com CEO and president Yuichi Iwaki said at today.
BioWorld @BioWorldπŸ”Panelists at regenerative medicine panel have high praise for Japan's regulatory reforms, citing direct and helpful twitter.com reactions with PMDA and the value of full reimbursement under accelerated approval.
BioWorld @BioWorldπŸ”Remember that $133M deal Mirati Therapeutics signed with Beigene in January? At , Mirati's Christopher LeMasters says twitter.com that, in light of the many many combo I-O trials underway, a key win was unlocking access to new trial populations in China.
BioWorld @BioWorldπŸ”Value-based healthcare, assessed via new technologies, will be key to reaching agreement between parties on pricing, twitter.com Takeda's Haruhiko Hirate said at . Innovation, on which Takeda has "bet its life," he said, will be key.
BioWorld @BioWorldπŸ”Unsurprisingly, Japanese reforms tightening reimbursement of innovative therapies are coming under broad criticism a twitter.com t . Though pressure is seen from Ministry of Health, Takeda's Haruhiko Hirate reminds audience that pressure is coming from the Ministry of Finance.
Michael Fitzhugh @mfitzπŸ” Rise and shine! Our coverage of #BIOASIA18 from @mfitz starts today!
BioWorld @BioWorldπŸ”BIO president and CEO Jim Greenwood at : This year's Japanese govt. budget (price maintenance premium) undermines the twitter.com development of innovative therapies. Puts smaller biotechs, including Japanese firms, at a disadvantage.
BioWorld @BioWorldπŸ” is revving up this morning in Tokyo with a welcome from Jim Greenwood: 420+ attendees from more than 30 countries. twitter.com will sharing highlights and news from the meeting throughout. Looking forward to meeting you!
BioWorld @BioWorldπŸ”Rise and shine! Our coverage of #BIOASIA18 from @mfitz starts today!
BrainStorm @BrainstormCellπŸ”Brainstorm President & CEO Chaim Lebovits and COO & CMO Ralph Kern, M.D., PhD., will present a corporate overview at twitter.com upcoming conferences and the Wall Street Investor Forum. See press release for presentation details:
Marie Powers @mariempowersπŸ” Starting Monday, look for @BioWorld coverage of #BIOASIA18 from @mfitz
BioWorld @BioWorldπŸ”Starting Monday, look for @BioWorld coverage of #BIOASIA18 from @mfitz
loading...
Almac Group @AlmacGroupπŸ”The Discovery experts are travelling to , to attend from 19-22 March. Click here to request a meeting with one of twitter.com our representatives :
BioWorld @BioWorldπŸ” I am, too! @BioWorld covering the world, from #BIOEuropeSpring to #BIOASIA18 twitter.com
Marie Powers @mariempowersπŸ”I am, too! @BioWorld covering the world, from #BIOEuropeSpring to #BIOASIA18 twitter.com
BioWorld @BioWorldπŸ” Looking forward to reading @mfitz's #BIOASIA18 coverage in @BioWorld! twitter.com
Donald Johnston @JohnstonDonπŸ”Looking forward to reading @mfitz's #BIOASIA18 coverage in @BioWorld! twitter.com
Marie Powers @mariempowersπŸ”Tokyo, here I come! Looking forward to making new connections and learning about innovative work underway during next week's .
Michael Fitzhugh @mfitzπŸ”Tokyo, here I come! Looking forward to making new connections and learning about innovative work underway during next week's #BIOASIA18.
BIO 1x1 Partnering @bio1x1πŸ”New program details for have been announced! See the panelists for Rewarding Innovation: Challenges and Opportuniti twitter.com es as Japan Implements Reimbursement Reform, Next-Generation Oncology Treatments: CAR-T and Beyond, and more.
Inova @Inova_SoftwareπŸ”Global partnerships are slowly becoming the norm in Japanese pharma companies. Top Japanese pharma companies are alre twitter.com ady using a partnering software like ours. Meet us at the upcoming in Tokyo next week to learn more:
BioPartner UK @BioPartnerπŸ”Are you interested in learning more about Discovery's hit finding platform? Why not set up a meeting with one of our Discovery experts at to find out more. Click here to request a meeting :
Almac Group @AlmacGroupπŸ”Are you interested in learning more about Discovery's hit finding platform? Why not set up a meeting with one of our twitter.com Discovery experts at to find out more. Click here to request a meeting :

05

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive